MARCH-APRIL-MAY 2015 US-FDA APPROVED DRUGS
MARCH 2015 US-FDA APPROVED DRUGS
1. TRADE (BRAND) NAME- Cresemba
ACTIVE PHARMACEUTICAL INGREDIENT- Isavuconazonium sulfate
COMPANY NAME- Astellas
USE- Isavuconazonium sulfate is a prodrug of 'isavuconazole' which is a triazole anti-fungal drug. It inhibits lanosterol 14-alpha demethylase-an enzyme which is responsible for the conversion of lanosterol to ergosterol- the building block for fungal cell walls. It is approved for the treatment of invasive aspergillosis (a fungal infection which mostly affects lungs and usually occurs with patients with tuberculosis and chronic obstructive pulmonary disorders-COPD) and invasive mucormycosis (a fungal infection mainly affecting the lungs, sinuses and brain).
ISAVUCONAZONIUM SULFATE
2. TRADE (BRAND) NAME- Cholbam
ACTIVE PHARMACEUTICAL INGREDIENT- Cholic acid
COMPANY NAME- Asklepion Pharmaceuticals
USE- Cholic acid is one of the major bile acids which is produced in the liver of human body from cholesterol. It decreases the effectiveness or downregulation of cholesterol-7-alpha hydrolase - a rate limiting step of bile acid synthesis. Cholbam capsules are approved for the treatment of bile acid synthesis disorders as well as peroxisomal disorders.
CHOLIC ACID
3. TRADE (BRAND) NAME- Opdivo
ACTIVE PHARMACEUTICAL INGREDIENT- Nivolumab
COMPANY NAME- Bristol-Myers Squibb
USE- Nivolumab is a humanized whole IgG 4 anti- PD 1 (programmed cell death receptor) monoclonal antibody which acts as an immunomodulator by blocking ligand activation of PD-1 receptor on activated T-cells. It is approved for the use of metastatic melanoma, squamous non-small cell ling cancer and Hodgkin's lymphoma.
4. TRADE (BRAND) NAME- Unituxin
ACTIVE PHARMACEUTICAL INGREDIENT- Dinutuximab
COMPANY NAME- United Therapeutics
USE- Dinutuximab is a chimeric (human/mouse) monoclonal antibody developed for the pediatrics with high-risk neuroblastoma.
APRIL 2015 US-FDA APPROVED DRUGS
1. TRADE (BRAND) NAME- Kybella
ACTIVE PHARMACEUTICAL INGREDIENT- Deoxycholic acid
COMPANY NAME- Kythera Biopharma
USE- Deoxycholic acid is one of the secondary bile acid which is the metabolic by-products of intestinal bacterial. It is used in the emulsification of fats for the absorption of intestine. It is used for destroying the moderate to high amount of fat below the chin in the submental triangle.
DEOXYCHOLIC ACID
2. TRADE (BRAND) NAME- Corlanor
ACTIVE PHARMACEUTICAL INGREDIENT- Ivabradine
COMPANY NAME- Amgen
USE- Ivabradine is a cardiotonic agent, anti-anginal agent whose mechanism differs the usual anti-anginal drugs like beta blockers, calcium channel blockers. It blocks the "funny" ion current which is highly active in the sinoatrial node. "Funny" ion current is a mixed sodium-potassium inward current activated by hyperpolarization. Thus, by blocking this ion current it slows the heart rate and reduces cardiac pace-maker activity. It is approved for the treatment of chronic heart failure.
COMPANY NAME- Actavis
USE- Eluxadoline is a mu- and kappa- opioid receptor agonist and delta- receptor antagonist. It is a novel orally-acting drug acts locally on enteric nervous system and thus decreasing the adverse effects on central nervous system. It is approved for the treatment of irritable bovel syndrome (IBS) with diarrhea and abdominal pain.
ELUXADOLINE
2. TRADE (BRAND) NAME- Xifaxan
ACTIVE PHARMACEUTICAL INGREDIENT- Rifaximin
COMPANY NAME- Salix Pharmaceuticals
USE- Rifaximin is a semi-synthetic antibiotic based on rifamycin. It is also approved for the treatment of IBS and thus relieving bloating and flatulence associated with it. Rifaximin binds to the beta subunit of bacterial RNA-polymerase and thus blocking translocation step, inhibiting transcription.
RIFAXIMIN
3. TRADE (BRAND) NAME- Stiolto Respimat
ACTIVE PHARMACEUTICAL INGREDIENT- Tiotropium bromide and Olodaterol
COMPANY NAME- Boehringer Ingelheim
USE- Tiotropium bromide is a long acting anticholinergic (muscarinic receptor antagonist) bronchodilator used for the maintainance of COPD which includes chronic bronchitis and emphysema.
Olodaterol is a long acting beta-adrenoreceptor agonist used for the maintainance of COPD including chronic bronchitis and emphysema.
TIOTROPIUM BROMIDE
OLODATEROL
MARCH 2015 US-FDA APPROVED DRUGS
1. TRADE (BRAND) NAME- Cresemba
ACTIVE PHARMACEUTICAL INGREDIENT- Isavuconazonium sulfate
COMPANY NAME- Astellas
USE- Isavuconazonium sulfate is a prodrug of 'isavuconazole' which is a triazole anti-fungal drug. It inhibits lanosterol 14-alpha demethylase-an enzyme which is responsible for the conversion of lanosterol to ergosterol- the building block for fungal cell walls. It is approved for the treatment of invasive aspergillosis (a fungal infection which mostly affects lungs and usually occurs with patients with tuberculosis and chronic obstructive pulmonary disorders-COPD) and invasive mucormycosis (a fungal infection mainly affecting the lungs, sinuses and brain).
ISAVUCONAZONIUM SULFATE
2. TRADE (BRAND) NAME- Cholbam
ACTIVE PHARMACEUTICAL INGREDIENT- Cholic acid
COMPANY NAME- Asklepion Pharmaceuticals
USE- Cholic acid is one of the major bile acids which is produced in the liver of human body from cholesterol. It decreases the effectiveness or downregulation of cholesterol-7-alpha hydrolase - a rate limiting step of bile acid synthesis. Cholbam capsules are approved for the treatment of bile acid synthesis disorders as well as peroxisomal disorders.
CHOLIC ACID
3. TRADE (BRAND) NAME- Opdivo
ACTIVE PHARMACEUTICAL INGREDIENT- Nivolumab
COMPANY NAME- Bristol-Myers Squibb
USE- Nivolumab is a humanized whole IgG 4 anti- PD 1 (programmed cell death receptor) monoclonal antibody which acts as an immunomodulator by blocking ligand activation of PD-1 receptor on activated T-cells. It is approved for the use of metastatic melanoma, squamous non-small cell ling cancer and Hodgkin's lymphoma.
4. TRADE (BRAND) NAME- Unituxin
ACTIVE PHARMACEUTICAL INGREDIENT- Dinutuximab
COMPANY NAME- United Therapeutics
USE- Dinutuximab is a chimeric (human/mouse) monoclonal antibody developed for the pediatrics with high-risk neuroblastoma.
APRIL 2015 US-FDA APPROVED DRUGS
1. TRADE (BRAND) NAME- Kybella
ACTIVE PHARMACEUTICAL INGREDIENT- Deoxycholic acid
COMPANY NAME- Kythera Biopharma
USE- Deoxycholic acid is one of the secondary bile acid which is the metabolic by-products of intestinal bacterial. It is used in the emulsification of fats for the absorption of intestine. It is used for destroying the moderate to high amount of fat below the chin in the submental triangle.
DEOXYCHOLIC ACID
2. TRADE (BRAND) NAME- Corlanor
ACTIVE PHARMACEUTICAL INGREDIENT- Ivabradine
COMPANY NAME- Amgen
USE- Ivabradine is a cardiotonic agent, anti-anginal agent whose mechanism differs the usual anti-anginal drugs like beta blockers, calcium channel blockers. It blocks the "funny" ion current which is highly active in the sinoatrial node. "Funny" ion current is a mixed sodium-potassium inward current activated by hyperpolarization. Thus, by blocking this ion current it slows the heart rate and reduces cardiac pace-maker activity. It is approved for the treatment of chronic heart failure.
IVABRADINE
MAY 2015 US-FDA APPROVED DRUGS
1. TRADE (BRAND) NAME- Viberzi
ACTIVE PHARMACEUTICAL INGREDIENT- EluxadolineCOMPANY NAME- Actavis
USE- Eluxadoline is a mu- and kappa- opioid receptor agonist and delta- receptor antagonist. It is a novel orally-acting drug acts locally on enteric nervous system and thus decreasing the adverse effects on central nervous system. It is approved for the treatment of irritable bovel syndrome (IBS) with diarrhea and abdominal pain.
ELUXADOLINE
2. TRADE (BRAND) NAME- Xifaxan
ACTIVE PHARMACEUTICAL INGREDIENT- Rifaximin
COMPANY NAME- Salix Pharmaceuticals
USE- Rifaximin is a semi-synthetic antibiotic based on rifamycin. It is also approved for the treatment of IBS and thus relieving bloating and flatulence associated with it. Rifaximin binds to the beta subunit of bacterial RNA-polymerase and thus blocking translocation step, inhibiting transcription.
RIFAXIMIN
3. TRADE (BRAND) NAME- Stiolto Respimat
ACTIVE PHARMACEUTICAL INGREDIENT- Tiotropium bromide and Olodaterol
COMPANY NAME- Boehringer Ingelheim
USE- Tiotropium bromide is a long acting anticholinergic (muscarinic receptor antagonist) bronchodilator used for the maintainance of COPD which includes chronic bronchitis and emphysema.
Olodaterol is a long acting beta-adrenoreceptor agonist used for the maintainance of COPD including chronic bronchitis and emphysema.
TIOTROPIUM BROMIDE
OLODATEROL